About Viridos
Viridos develops genomic-driven solutions to address global energy and environmental challenges.
Headquarters
Viridos, La Jolla
Founded
2005-01-01
Industry
Biotechnology, Health Care, Medical, Renewable Energy
Last Funding Type
Series A
Valuation
1
Total Funding
$202.00 million dollars
IPO Status
Private
Financial
Viridos is focused on developing genetically modified algae to enhance lipid and biomass productivity. Their research includes creating recombinant algal mutants with modifications in genes encoding WD40 repeat proteins, trehalose biosynthetic enzymes, and protein kinase-like proteins. These modifications result in higher lipid and biomass productivity. Additionally, they explore mutant photosynthetic microorganisms with reduced chlorophyll for increased productivity and Chlorophyte algae with improved productivity through genetic modifications in chloroplastic signal recognition particles.
Funding Rounds
10
Number of Lead Investors
5
Total Funding Amount
$202.00 million dollars
Number of Investors
12